Copyright
©The Author(s) 2025.
World J Gastroenterol. Jul 14, 2025; 31(26): 105656
Published online Jul 14, 2025. doi: 10.3748/wjg.v31.i26.105656
Published online Jul 14, 2025. doi: 10.3748/wjg.v31.i26.105656
Figure 6 Effects of kushenol I on cluster of differentiation 3-positive (CD3+), cluster of differentiation 4-positive (CD4+), and cluster of differentiation 8-positive (CD8+) T-cell subpopulations, and the CD4+/CD8+ ratio in the spleens of mice with ulcerative colitis.
Values are presented as the mean ± standard error of the mean (n = 3). aP < 0.05. bP < 0.01. cP < 0.001. P compared with the model group. APC-H: Allophycocyanin-height; CD: Cluster of differentiation; FITC-H: Fluorescein isothiocyanate-height; PE-H: Phycoerythrin-height; SSC-H: Side scatter height.
- Citation: He XD, Li M, Zuo XD, Ni HY, Han YX, Hu YK, Yu J, Yang XX. Kushenol I combats ulcerative colitis via intestinal barrier preservation and gut microbiota optimization. World J Gastroenterol 2025; 31(26): 105656
- URL: https://www.wjgnet.com/1007-9327/full/v31/i26/105656.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i26.105656